Otrivin Menthol Utan Konserveringsmedel (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin Menthol Utan Konserveringsmedel, is a nasal decongestant presented as a nasal spray for intranasal use. It relieves nasal congestion caused by colds, allergic rhinitis and sinusitis in adults and children. GNH USA supplies Otrivin Menthol Utan Konserveringsmedel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline hydrochloride is an alpha‑adrenergic nasal decongestant that reduces swelling of the nasal mucosa. - Common cold: alleviates nasal blockage and improves airflow. - Allergic rhinitis: decreases nasal congestion associated with seasonal or perennial allergies. - Acute sinusitis: helps relieve nasal obstruction during early stages of sinus infection.

Xylometazoline nasal spray may cause a range of adverse reactions.

Common Side Effects: - Burning sensation in the nose: mild to moderate discomfort at the application site. - Nasal dryness: reduced moisture leading to crust formation. - Sneezing: transient reflex after spray. - Headache: mild tension‑type headache.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heartbeat reported rarely. - Severe allergic reaction: rash, swelling or difficulty breathing.

Before using Otrivin Menthol Utan Konserveringsmedel, consider the following precautions. - Duration of use: limit to no more than 3‑5 days to avoid rebound congestion. - Cardiovascular disease: use with caution in patients with hypertension or heart disease. - Pregnancy: consult a healthcare professional before use during pregnancy. - Breastfeeding: discuss potential risks with a physician before use while nursing. - Children under 2 years: not recommended unless specifically prescribed. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other sympathomimetic agents and certain systemic medications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstrictive effect may increase blood pressure.

Moderate Interactions (Monitor Closely):\n- Antihypertensive drugs: possible reduction in antihypertensive efficacy. - Tricyclic antidepressants: may enhance sympathomimetic activity. - Beta‑blockers: monitor for increased cardiovascular effects.